Glen Santangelo
Stock Analyst at Barclays
(3.33)
# 1,056
Out of 5,113 analysts
111
Total ratings
54.67%
Success rate
1.74%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Overweight | $26 → $24 | $16.27 | +47.51% | 3 | Dec 16, 2025 | |
| ZTS Zoetis | Initiates: Equal-Weight | $136 | $123.51 | +10.11% | 2 | Dec 9, 2025 | |
| XERS Xeris Biopharma Holdings | Initiates: Overweight | $9 | $7.19 | +25.17% | 3 | Dec 9, 2025 | |
| VTRS Viatris | Initiates: Overweight | $15 | $11.94 | +25.63% | 5 | Dec 9, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Overweight | $35 | $30.25 | +15.72% | 5 | Dec 9, 2025 | |
| TDOC Teladoc Health | Initiates: Equal-Weight | $8.5 | $7.27 | +16.92% | 8 | Dec 9, 2025 | |
| TARS Tarsus Pharmaceuticals | Initiates: Overweight | $100 | $79.04 | +26.52% | 1 | Dec 9, 2025 | |
| TALK Talkspace | Initiates: Equal-Weight | $3.5 | $3.54 | -0.99% | 2 | Dec 9, 2025 | |
| PGNY Progyny | Initiates: Overweight | $29 | $26.23 | +10.56% | 5 | Dec 9, 2025 | |
| PHAT Phathom Pharmaceuticals | Initiates: Equal-Weight | $16 | $16.92 | -5.44% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $26.21 | +3.01% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $77.38 | +11.14% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $118 | $95.95 | +22.98% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $3 | $2.75 | +9.09% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $22.13 | +8.45% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $21.98 | +36.49% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $63 | $43.79 | +43.87% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.20 | +7.14% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $58 | $49.33 | +17.58% | 4 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $400 | $344.03 | +16.27% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $243 | $201.65 | +20.51% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8 | $6.98 | +14.61% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $84.06 | +18.96% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $26.58 | +12.87% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.64 | +18.67% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $38.27 | +28.05% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $4.83 | +3.52% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $170 | $159.55 | +6.55% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $7.5 | $6.83 | +9.81% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $960 | $822.09 | +16.78% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $850 | $700.91 | +21.27% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $34.63 | +38.61% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $32.63 | +56.30% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $8.03 | +1,145.33% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $42.75 | +28.65% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.34 | +1,096.58% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.78 | +2,410.46% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.47 | +1,357.49% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $78.30 | - | 3 | Mar 17, 2021 |
Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $16.27
Upside: +47.51%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $123.51
Upside: +10.11%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.19
Upside: +25.17%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $11.94
Upside: +25.63%
Teva Pharmaceutical Industries
Dec 9, 2025
Initiates: Overweight
Price Target: $35
Current: $30.25
Upside: +15.72%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $7.27
Upside: +16.92%
Tarsus Pharmaceuticals
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $79.04
Upside: +26.52%
Talkspace
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.54
Upside: -0.99%
Progyny
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $26.23
Upside: +10.56%
Phathom Pharmaceuticals
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $16.92
Upside: -5.44%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $26.21
Upside: +3.01%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $77.38
Upside: +11.14%
Dec 9, 2025
Initiates: Overweight
Price Target: $118
Current: $95.95
Upside: +22.98%
Dec 9, 2025
Initiates: Underweight
Price Target: $3
Current: $2.75
Upside: +9.09%
Dec 9, 2025
Initiates: Overweight
Price Target: $24
Current: $22.13
Upside: +8.45%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $21.98
Upside: +36.49%
Dec 9, 2025
Initiates: Overweight
Price Target: $63
Current: $43.79
Upside: +43.87%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.20
Upside: +7.14%
Dec 9, 2025
Initiates: Overweight
Price Target: $58
Current: $49.33
Upside: +17.58%
Dec 9, 2025
Initiates: Overweight
Price Target: $400
Current: $344.03
Upside: +16.27%
Dec 9, 2025
Initiates: Overweight
Price Target: $243
Current: $201.65
Upside: +20.51%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8
Current: $6.98
Upside: +14.61%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $84.06
Upside: +18.96%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $26.58
Upside: +12.87%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.64
Upside: +18.67%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $38.27
Upside: +28.05%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $4.83
Upside: +3.52%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $170
Current: $159.55
Upside: +6.55%
Dec 9, 2025
Initiates: Underweight
Price Target: $7.5
Current: $6.83
Upside: +9.81%
Dec 9, 2025
Initiates: Overweight
Price Target: $960
Current: $822.09
Upside: +16.78%
Dec 9, 2025
Initiates: Overweight
Price Target: $850
Current: $700.91
Upside: +21.27%
Dec 9, 2025
Initiates: Overweight
Price Target: $48
Current: $34.63
Upside: +38.61%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $32.63
Upside: +56.30%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $8.03
Upside: +1,145.33%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $42.75
Upside: +28.65%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.34
Upside: +1,096.58%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.78
Upside: +2,410.46%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.47
Upside: +1,357.49%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $78.30
Upside: -